HomePharma

Pharma

Pharma

Zai Lab Begins Global Phase 1/1b Trial of ZL-1503 for Atopic Dermatitis

Life Sciences Times - 0
Pharma

Amylyx Pharmaceuticals Reports New Cohort 1 Safety Data for AMX0114 in ALS from First-in-Human LUMINA Trial

Life Sciences Times - 0
Pharma

Alzheon Highlights New Peer-Reviewed Evidence Supporting Hippocampal Volume as a Surrogate Marker in Early Alzheimer’s Disease

Life Sciences Times - 0
Pharma

Baxdrostat Receives FDA Priority Review for Hard-to-Control Hypertension

Life Sciences Times - 0
Pharma

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

Life Sciences Times - 0
Pharma

AstraZeneca’s IMFINZI Gets First U.S. Approval for Perioperative Use in Early Gastric and GEJ Cancers

Life Sciences Times - 0
Pharma

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

Life Sciences Times - 0
Pharma

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

Life Sciences Times - 0
Pharma

PharmaEssentia Highlights Publication of Phase 3 SURPASS-ET Trial Results in The Lancet Haematology

Life Sciences Times - 0
Pharma

FDA Approves Promega OncoMate MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA and LENVIMA in Advanced Endometrial Carcinoma

Life Sciences Times - 0
Pharma

City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant

Life Sciences Times - 0
Pharma

AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome

Life Sciences Times - 0
1...789...91Page 8 of 91

Most Read